Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
12:00:00 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5,666.00 JPY | +0.16% |
|
-1.51% | +17.19% |
| 09/09 | Takeda Publishes Phase 3 Data Demonstrating Oveporexton Improves Narcolepsy Type 1 Symptoms | CI |
| 08/09 | Pharvaris' genetic disorder drug meets main goal in late-stage trial | RE |
| Market Cap | 9,04700Cr 5.89TCr 5.08TCr 4.81TCr 4.36TCr 8.17TCr 5,62800Cr 8.21TCr 57TCr 22TCr 2,86300Cr 22TCr 22TCr | P/E 2027 * |
44.9x | P/E 2028 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise Value | 12,95400Cr 8.43TCr 7.27TCr 6.88TCr 6.24TCr 12TCr 8,05800Cr 12TCr 82TCr 31TCr 4,09900Cr 32TCr 31TCr | EV / Sales 2027 * |
2.76x | EV / Sales 2028 * | 2.67x |
| Free-Float |
99.26% | Yield 2027 * |
3.61% | Yield 2028 * | 3.68% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
OTC Markets
| TKPHF | Delayed | |
|
Tradegate
| TKD | Real-time | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
Börse Stuttgart
| TKD | Delayed | |
|
Boerse Muenchen
| TKD | Real-time | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript : Takeda Pharmaceutical Company Limited
| 1 day | +0.16% | ||
| 1 week | -1.51% | ||
| Current month | -1.72% | ||
| 1 month | +1.50% | ||
| 3 months | +12.58% | ||
| 6 months | -1.53% | ||
| Current year | +17.19% |
| 1 week | 5,557 |  | 5,826 |
| 1 month | 5,504 | | 5,917 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Sell | Chief Technology Officer | -1,16,191 | 0.0073% | ||
| 19/08/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% | ||
| 18/08/26 | Sell | Head of Human Resources | -12,980 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -1.51% | +25.80% | +24.66% | 5.89TCr | |
| -0.65% | -2.93% | +47.52% | +87.34% | 99TCr | |
| -0.29% | -3.51% | +48.78% | +63.27% | 64TCr | |
| +0.83% | +0.26% | +16.76% | +72.52% | 45TCr | |
| -0.38% | -3.59% | +28.24% | +35.57% | 34TCr | |
| -0.09% | -13.54% | +10.08% | +26.87% | 26TCr | |
| -0.43% | -2.48% | -2.07% | +11.48% | 25TCr | |
| -1.34% | -13.70% | +33.47% | +44.18% | 20TCr | |
| -3.44% | -7.51% | -20.08% | -59.58% | 19TCr | |
| -0.75% | -4.82% | +21.94% | +86.55% | 18TCr | |
| Average | -0.64% | -5.33% | +21.04% | +39.29% | 35.64TCr | |
| Weighted average by Cap. | -0.50% | -4.37% | +29.80% | +55.20% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,70100Cr 3.06TCr 2.64TCr 2.5TCr 2.26TCr 4.25TCr 2,92400Cr 4.27TCr 30TCr 11TCr 1,48800Cr 11TCr 11TCr | 4,78100Cr 3.11TCr 2.68TCr 2.54TCr 2.3TCr 4.32TCr 2,97400Cr 4.34TCr 30TCr 12TCr 1,51300Cr 12TCr 11TCr |
| Net income | 20TCr 127.94Cr 110.23Cr 104.38Cr 95Cr 177.49Cr 12TCr 178.39Cr 1.24TCr 476.7Cr 6.22TCr 480.49Cr 469.95Cr | 32TCr 209.94Cr 180.89Cr 171.28Cr 155.24Cr 291.25Cr 20TCr 292.72Cr 2.03TCr 782.25Cr 10TCr 788.46Cr 771.16Cr |
| Net Debt | 3,90700Cr 2.54TCr 2.19TCr 2.08TCr 1.88TCr 3.53TCr 2,43000Cr 3.55TCr 25TCr 9.48TCr 1,23600Cr 9.55TCr 9.34TCr | 3,70200Cr 2.41TCr 2.08TCr 1.97TCr 1.78TCr 3.34TCr 2,30300Cr 3.36TCr 23TCr 8.98TCr 1,17200Cr 9.05TCr 8.85TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | JP¥5,666.00 | +0.16% | 42,55,100 |
| 10/26/10 | JP¥5,657.00 | +0.75% | 44,93,300 |
| 09/26/09 | JP¥5,615.00 | -2.52% | 55,30,300 |
| 08/26/08 | JP¥5,760.00 | -0.29% | 24,67,300 |
| 07/26/07 | JP¥5,777.00 | +0.42% | 23,96,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
